Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical Trial.

Lloyd M, Karahalios A, Janus E, Skinner EH, Haines T, De Silva A, Lowe S, Shackell M, Ko S, Desmond L, Karunajeewa H; Improving Evidence-Based Treatment Gaps and Outcomes in Community-Acquired Pneumonia (IMPROVE-GAP) Implementation Team at Western Health.

JAMA Intern Med. 2019 Jul 8. doi: 10.1001/jamainternmed.2019.1438. [Epub ahead of print]

PMID:
31282921
2.

Patient-reported outcome measures in community-acquired pneumonia: a systematic review of application and content validity.

Lloyd M, Callander E, Karahalios A, Desmond L, Karunajeewa H.

BMJ Open Respir Res. 2019 Jun 2;6(1):e000398. doi: 10.1136/bmjresp-2018-000398. eCollection 2019.

4.

Is the epidemiology of Plasmodium knowlesi changing and what does this mean for malaria control in South East Asia?

Karunajeewa H, Berman J.

Clin Infect Dis. 2019 Mar 19. pii: ciz238. doi: 10.1093/cid/ciz238. [Epub ahead of print] No abstract available.

PMID:
30888013
5.

Evidence-based management of patients with vertigo, dizziness, and imbalance at an Australian metropolitan health service: an observational study of clinical practice.

Lloyd M, Mackintosh A, Grant C, McManus F, Kelly AM, Karunajeewa H, Tang CY.

Physiother Theory Pract. 2018 Oct 17:1-8. doi: 10.1080/09593985.2018.1511020. [Epub ahead of print]

PMID:
30332324
6.

Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.

Millat-Martínez P, Ila R, Laman M, Robinson L, Karunajeewa H, Abel H, Pulai K, Sanz S, Manning L, Moore B, Bassat Q, Mitjà O.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01153-18. doi: 10.1128/AAC.01153-18. Print 2018 Dec.

7.

Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.

Thriemer K, Bobogare A, Ley B, Gudo CS, Alam MS, Anstey NM, Ashley E, Baird JK, Gryseels C, Jambert E, Lacerda M, Laihad F, Marfurt J, Pasaribu AP, Poespoprodjo JR, Sutanto I, Taylor WR, van den Boogaard C, Battle KE, Dysoley L, Ghimire P, Hawley B, Hwang J, Khan WA, Mudin RNB, Sumiwi ME, Ahmed R, Aktaruzzaman MM, Awasthi KR, Bardaji A, Bell D, Boaz L, Burdam FH, Chandramohan D, Cheng Q, Chindawongsa K, Culpepper J, Das S, Deray R, Desai M, Domingo G, Duoquan W, Duparc S, Floranita R, Gerth-Guyette E, Howes RE, Hugo C, Jagoe G, Sariwati E, Jhora ST, Jinwei W, Karunajeewa H, Kenangalem E, Lal BK, Landuwulang C, Le Perru E, Lee SE, Makita LS, McCarthy J, Mekuria A, Mishra N, Naket E, Nambanya S, Nausien J, Duc TN, Thi TN, Noviyanti R, Pfeffer D, Qi G, Rahmalia A, Rogerson S, Samad I, Sattabongkot J, Satyagraha A, Shanks D, Sharma SN, Sibley CH, Sungkar A, Syafruddin D, Talukdar A, Tarning J, Ter Kuile F, Thapa S, Theodora M, Huy TT, Waramin E, Waramori G, Woyessa A, Wongsrichanalai C, Xa NX, Yeom JS, Hermawan L, Devine A, Nowak S, Jaya I, Supargiyono S, Grietens KP, Price RN.

Malar J. 2018 Jun 20;17(1):241. doi: 10.1186/s12936-018-2380-8.

8.

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.

Kloprogge F, Workman L, Borrmann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Mårtensson A, Ngasala B, Björkman A, Ashton M, Friberg Hietala S, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Barnes KI, Tarning J.

PLoS Med. 2018 Jun 12;15(6):e1002579. doi: 10.1371/journal.pmed.1002579. eCollection 2018 Jun.

9.

The IMPROVE-GAP Trial aiming to improve evidence-based management of community-acquired pneumonia: study protocol for a stepped-wedge randomised controlled trial.

Skinner EH, Lloyd M, Janus E, Ong ML, Karahalios A, Haines TP, Kelly AM, Shackell M, Karunajeewa H.

Trials. 2018 Feb 5;19(1):88. doi: 10.1186/s13063-017-2407-4.

10.

Increasingly inbred and fragmented populations of Plasmodium vivax associated with the eastward decline in malaria transmission across the Southwest Pacific.

Waltmann A, Koepfli C, Tessier N, Karl S, Fola A, Darcy AW, Wini L, Harrison GLA, Barnadas C, Jennison C, Karunajeewa H, Boyd S, Whittaker M, Kazura J, Bahlo M, Mueller I, Barry AE.

PLoS Negl Trop Dis. 2018 Jan 26;12(1):e0006146. doi: 10.1371/journal.pntd.0006146. eCollection 2018 Jan.

11.

Quantifying the hidden healthcare cost of diabetes mellitus in Australian hospital patients.

Karahalios A, Somarajah G, Hamblin PS, Karunajeewa H, Janus ED.

Intern Med J. 2018 Mar;48(3):286-292. doi: 10.1111/imj.13685.

PMID:
29193646
12.

Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling.

Salman S, Baiwog F, Page-Sharp M, Kose K, Karunajeewa HA, Mueller I, Rogerson SJ, Siba PM, Ilett KF, Davis TME.

Int J Antimicrob Agents. 2017 Oct;50(4):542-551. doi: 10.1016/j.ijantimicag.2017.05.011. Epub 2017 Jun 29.

PMID:
28669839
13.

Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.

Salman S, Baiwog F, Page-Sharp M, Griffin S, Karunajeewa HA, Mueller I, Rogerson SJ, Siba PM, Ilett KF, Davis TME.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02291-16. doi: 10.1128/AAC.02291-16. Print 2017 May.

14.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke GM, Rockett K, Kivinen K, Hubbart C, Jeffreys AE, Rowlands K, Jallow M, Conway DJ, Bojang KA, Pinder M, Usen S, Sisay-Joof F, Sirugo G, Toure O, Thera MA, Konate S, Sissoko S, Niangaly A, Poudiougou B, Mangano VD, Bougouma EC, Sirima SB, Modiano D, Amenga-Etego LN, Ghansah A, Koram KA, Wilson MD, Enimil A, Evans J, Amodu OK, Olaniyan S, Apinjoh T, Mugri R, Ndi A, Ndila CM, Uyoga S, Macharia A, Peshu N, Williams TN, Manjurano A, Sepúlveda N, Clark TG, Riley E, Drakeley C, Reyburn H, Nyirongo V, Kachala D, Molyneux M, Dunstan SJ, Phu NH, Quyen NN, Thai CQ, Hien TT, Manning L, Laman M, Siba P, Karunajeewa H, Allen S, Allen A, Davis TM, Michon P, Mueller I, Molloy SF, Campino S, Kerasidou A, Cornelius VJ, Hart L, Shah SS, Band G, Spencer CC, Agbenyega T, Achidi E, Doumbo OK, Farrar J, Marsh K, Taylor T, Kwiatkowski DP; MalariaGEN Consortium.

Elife. 2017 Jan 9;6. pii: e15085. doi: 10.7554/eLife.15085.

15.

Intensive vs Standard Blood Pressure Control for Older Adults.

Dimitri M, Janus E, Karunajeewa H.

JAMA. 2016 Nov 8;316(18):1921-1922. doi: 10.1001/jama.2016.14921. No abstract available.

PMID:
27825003
16.

How important is gametocyte clearance after malaria therapy?

Karunajeewa HA, Mueller I.

BMC Med. 2016 Jun 18;14:93. doi: 10.1186/s12916-016-0641-3.

17.

False economies in home-based parenteral antibiotic treatment: a health-economic case study of management of lower-limb cellulitis in Australia-authors' response.

Kameshwar K, Karahalios A, Janus E, Karunajeewa H.

J Antimicrob Chemother. 2016 Aug;71(8):2363. doi: 10.1093/jac/dkw140. Epub 2016 May 5. No abstract available.

PMID:
27150394
18.

False economies in home-based parenteral antibiotic treatment: a health-economic case study of management of lower-limb cellulitis in Australia.

Kameshwar K, Karahalios A, Janus E, Karunajeewa H.

J Antimicrob Chemother. 2016 Mar;71(3):830-5. doi: 10.1093/jac/dkv413. Epub 2015 Dec 24.

PMID:
26702920
19.

A Retrospective Review: Significance of Vegetation Size in Injection Drug Users with Right-Sided Infective Endocarditis.

Otome O, Guy S, Tramontana A, Lane G, Karunajeewa H.

Heart Lung Circ. 2016 May;25(5):466-70. doi: 10.1016/j.hlc.2015.10.013. Epub 2015 Nov 18.

PMID:
26700022
20.

A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children.

Manning L, Cutts J, Stanisic DI, Laman M, Carmagnac A, Allen S, O'Donnell A, Karunajeewa H, Rosanas-Urgell A, Siba P, Davis TM, Michon P, Schofield L, Rockett K, Kwiatkowski D, Mueller I.

Genes Immun. 2016 Jan-Feb;17(1):52-9. doi: 10.1038/gene.2015.50. Epub 2015 Dec 3.

21.

Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.

Barnadas C, Timinao L, Javati S, Iga J, Malau E, Koepfli C, Robinson LJ, Senn N, Kiniboro B, Rare L, Reeder JC, Siba PM, Zimmerman PA, Karunajeewa H, Davis TM, Mueller I.

Malar J. 2015 Oct 9;14:399. doi: 10.1186/s12936-015-0879-9.

22.

Parasite clearance after malaria therapy: staying a step ahead of drug resistance.

Karunajeewa HA.

BMC Med. 2015 Oct 2;13:251. doi: 10.1186/s12916-015-0486-1.

23.

The true prevalence of diabetes in hospital patients and its implications.

Somarajah G, Karunajeewa H, Hamblin PS, Karahalios E, Janus E.

Intern Med J. 2015 May;45(5):594. doi: 10.1111/imj.12746. No abstract available.

PMID:
25955475
24.

Missing malaria? Potential obstacles to diagnosis and hypnozoite eradication.

Karunajeewa H, Waltmann A, Wini L, Mueller I.

Med J Aust. 2015 Apr 20;202(7):360. No abstract available.

PMID:
25877110
25.

Author reply: To PMID 24946819.

Williams E, Janus E, Karunajeewa H.

Intern Med J. 2014 Nov;44(11):1149. doi: 10.1111/imj.12575. No abstract available.

PMID:
25367734
26.

Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea.

Barnadas C, Senn N, Iga J, Timinao L, Javati S, Malau E, Rarau P, Reeder JC, Siba P, Karunajeewa H, Zimmerman PA, Davis TM, Mueller I.

Antimicrob Agents Chemother. 2014 Nov;58(11):6958-61. doi: 10.1128/AAC.03323-14. Epub 2014 Aug 25.

27.

CORB is the best pneumonia severity score for elderly hospitalised patients with suspected pneumonia.

Williams E, Girdwood J, Janus E, Karunajeewa H.

Intern Med J. 2014 Jun;44(6):613-5. doi: 10.1111/imj.12445.

PMID:
24946819
28.

Getting to the guts of the matter: the status and potential of 'omics' research of parasitic protists of the human gastrointestinal system.

Jex AR, Koehler AV, Ansell BR, Baker L, Karunajeewa H, Gasser RB.

Int J Parasitol. 2013 Nov;43(12-13):971-82. doi: 10.1016/j.ijpara.2013.06.005. Epub 2013 Jul 18. Review.

PMID:
23871821
29.

Diagnosis of tuberculous lymphadenitis using fine needle aspiration biopsy.

Knox J, Lane G, Wong JS, Trevan PG, Karunajeewa H.

Intern Med J. 2012 Sep;42(9):1029-36.

PMID:
22372860
30.

Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children.

Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, Warrell J, Rosanas-Urgell A, Lin E, Kiniboro B, Vince J, Hwaiwhanje I, Karunajeewa H, Michon P, Siba P, Mueller I, Davis TM.

PLoS One. 2011;6(12):e29203. doi: 10.1371/journal.pone.0029203. Epub 2011 Dec 22.

31.

Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.

Manning L, Laman M, Page-Sharp M, Salman S, Hwaiwhanje I, Morep N, Siba P, Mueller I, Karunajeewa HA, Davis TM.

Antimicrob Agents Chemother. 2011 Nov;55(11):5027-33. doi: 10.1128/AAC.00375-11. Epub 2011 Aug 22.

32.

Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.

Barnadas C, Koepfli C, Karunajeewa HA, Siba PM, Davis TM, Mueller I.

Antimicrob Agents Chemother. 2011 Sep;55(9):4479-81. doi: 10.1128/AAC.01552-10. Epub 2011 Jun 27.

33.

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea.

Davis WA, Clarke PM, Siba PM, Karunajeewa HA, Davy C, Mueller I, Davis TM.

Bull World Health Organ. 2011 Mar 1;89(3):211-20. doi: 10.2471/BLT.10.084103. Epub 2011 Feb 1.

34.

Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM.

PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932.

35.

Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay.

Wong RP, Karunajeewa H, Mueller I, Siba P, Zimmerman PA, Davis TM.

Antimicrob Agents Chemother. 2011 Feb;55(2):798-805. doi: 10.1128/AAC.00939-10. Epub 2010 Nov 15.

36.

Lumbar puncture in children from an area of malaria endemicity who present with a febrile seizure.

Laman M, Manning L, Hwaiwhange I, Vince J, Aipit S, Mare T, Warrel J, Karunajeewa H, Siba P, Mueller I, Davis TM.

Clin Infect Dis. 2010 Sep 1;51(5):534-40. doi: 10.1086/655679.

PMID:
20662714
37.

Neisseria lactamica arthritis and septicemia complicating myeloma.

Everts RJ, Speers D, George ST, Ansell BJ, Karunajeewa H, Ramos RD.

J Clin Microbiol. 2010 Jun;48(6):2318. doi: 10.1128/JCM.02132-09. Epub 2010 Apr 21. No abstract available.

38.

Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.

Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, Page-Sharp M, Rogerson S, Siba P, Ilett KF, Davis TM.

Antimicrob Agents Chemother. 2010 Mar;54(3):1186-92. doi: 10.1128/AAC.01269-09. Epub 2010 Jan 19.

39.

In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.

Wong RP, Lautu D, Tavul L, Hackett SL, Siba P, Karunajeewa HA, Ilett KF, Mueller I, Davis TM.

Trop Med Int Health. 2010 Mar;15(3):342-9. doi: 10.1111/j.1365-3156.2009.02463.x. Epub 2010 Jan 11.

40.

CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess.

von Ahsen N, Tzvetkov M, Karunajeewa HA, Gomorrai S, Ura A, Brockmöller J, Davis TM, Mueller I, Ilett KF, Oellerich M.

Int J Mol Epidemiol Genet. 2010 Aug 18;1(4):310-9.

41.

Investigation of reproductive toxicity of piperaquine in mice.

Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Rogerson SJ, Karunajeewa HA, Davis TM.

Reprod Toxicol. 2010 Apr;29(2):206-13. doi: 10.1016/j.reprotox.2009.10.013. Epub 2009 Nov 3.

PMID:
19892009
42.

Pharmacokinetic properties of azithromycin in pregnancy.

Salman S, Rogerson SJ, Kose K, Griffin S, Gomorai S, Baiwog F, Winmai J, Kandai J, Karunajeewa HA, O'Halloran SJ, Siba P, Ilett KF, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2010 Jan;54(1):360-6. doi: 10.1128/AAC.00771-09. Epub 2009 Oct 26.

43.

Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.

Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, Page-Sharp M, Rogerson S, Siba P, Ilett KF, Davis TM.

Antimicrob Agents Chemother. 2009 Oct;53(10):4368-76. doi: 10.1128/AAC.00335-09. Epub 2009 Jul 20.

44.

A trial of combination antimalarial therapies in children from Papua New Guinea.

Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM.

N Engl J Med. 2008 Dec 11;359(24):2545-57. doi: 10.1056/NEJMoa0804915. Epub 2008 Dec 8.

45.

Toxicology and pharmacokinetics of piperaquine in mice.

Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Karunajeewa HA, Davis TM.

Toxicology. 2008 Jul 10;249(1):55-61. doi: 10.1016/j.tox.2008.04.004. Epub 2008 Apr 16.

PMID:
18502018
46.

Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.

Gomes M, Ribeiro I, Warsame M, Karunajeewa H, Petzold M.

BMC Infect Dis. 2008 Mar 28;8:39. doi: 10.1186/1471-2334-8-39. Review.

47.

Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers.

Law I, Ilett KF, Hackett LP, Page-Sharp M, Baiwog F, Gomorrai S, Mueller I, Karunajeewa HA, Davis TM.

Br J Clin Pharmacol. 2008 May;65(5):674-9. doi: 10.1111/j.1365-2125.2008.03111.x. Epub 2008 Feb 15.

48.

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.

Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, Lin E, Lammey J, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2008 Jan;52(1):237-43. Epub 2007 Oct 29.

49.

Rectal administration of artemisinin derivatives for the treatment of malaria.

Karunajeewa HA, Manning L, Mueller I, Ilett KF, Davis TM.

JAMA. 2007 Jun 6;297(21):2381-90. Review.

PMID:
17551131
50.

Caregivers' acceptance of using artesunate suppositories for treating childhood malaria in Papua New Guinea.

Hinton RL, Auwun A, Pongua G, Oa O, Davis TM, Karunajeewa HA, Reeder JC.

Am J Trop Med Hyg. 2007 Apr;76(4):634-40.

PMID:
17426162

Supplemental Content

Loading ...
Support Center